Algernon Pharmaceuticals Inc.
AGNPF
$0.0488
-$0.0022-4.31%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 105.57% | 93.25% | 92.52% | 59.65% | 17.42% |
| Total Depreciation and Amortization | -45.75% | -47.08% | -48.00% | -48.28% | -26.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -183.94% | -169.49% | -154.53% | -94.56% | 61.83% |
| Change in Net Operating Assets | -199.08% | -174.33% | -149.67% | -108.98% | 21.86% |
| Cash from Operations | -75.91% | -61.04% | -6.07% | 24.13% | 56.85% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8,539.70% | 5,583.17% | 3,941.95% | 2,270.51% | 70.12% |
| Cash from Investing | 8,539.70% | 5,583.17% | 3,941.95% | 2,270.51% | 70.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -75.36% | -46.83% | -51.19% | -84.72% | 3.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 214.14% | 312.23% | 312.23% | -75.08% | -88.12% |
| Cash from Financing | -58.45% | -27.02% | -32.71% | -82.94% | -32.59% |
| Foreign Exchange rate Adjustments | 1,100.00% | 333.33% | -300.00% | 200.00% | -118.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.60% | 145.70% | 136.20% | 140.14% | 90.86% |